Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Thymalfasin by SciClone Pharmaceuticals for Cystic Fibrosis: Likelihood of Approval
Thymalfasin is under clinical development by SciClone Pharmaceuticals and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...
Thymalfasin by SciClone Pharmaceuticals for Thymic Carcinoma: Likelihood of Approval
Thymalfasin is under clinical development by SciClone Pharmaceuticals and currently in Phase II for Thymic Carcinoma. According to GlobalData, Phase...
Thymalfasin by SciClone Pharmaceuticals for Thymoma (Thymic Epithelial Tumor): Likelihood of Approval
Thymalfasin is under clinical development by SciClone Pharmaceuticals and currently in Phase II for Thymoma (Thymic Epithelial Tumor). According to...